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The mechanisms by which methylated mammalian promoters are
transcriptionally silenced even in the presence of all of the factors
required for their expression have long been a major unresolved
issue in the field of epigenetics. Repression requires the assembly
of a methylation-dependent silencing complex that contains the
TRIM28 protein (also known as KAP1 and TIF1β), a scaffolding pro-
tein without intrinsic repressive or DNA-binding properties. The
identity of the key effector within this complex that represses
transcription is unknown. We developed a methylation-sensitized
interaction screen which revealed that TRIM28 was complexed with
O-linked β-N-acetylglucosamine transferase (OGT) only in cells that
had normal genomic methylation patterns. OGT is the only glyco-
syltransferase that modifies cytoplasmic and nuclear protein by
transfer of N-acetylglucosamine (O-GlcNAc) to serine and threonine
hydroxyls. Whole-genome analysis showed thatO-glycosylated pro-
teins and TRIM28 were specifically bound to promoters of active
retrotransposons and to imprinting control regions, the two major
regulatory sequences controlled by DNA methylation. Furthermore,
genome-wide loss of DNA methylation caused a loss of O-GlcNAc
from multiple transcriptional repressor proteins associated with
TRIM28. A newly developed Cas9-based editing method for tar-
geted removal of O-GlcNAc was directed against retrotransposon
promoters. Local chromatin de-GlcNAcylation specifically reacti-
vated the expression of the targeted retrotransposon family with-
out loss of DNA methylation. These data revealed that O-linked
glycosylation of chromatin factors is essential for the transcriptional
repression of methylated retrotransposons.
DNA methylation | protein O-glycosylation | gene silencing
It has been known for many years that the methylation ofmammalian promoters induces heritable transcriptional re-
pression (1–3). Genome-wide demethylation reactivates expres-
sion of silenced retrotransposons (4) and causes the biallelic
expression of imprinted genes (5), which are normally expressed
from only the allele of maternal or paternal origin. After intro-
duction into cells, artificially methylated Pol II-dependent pro-
moters are actively transcribed for a brief period prior to heritable
silencing (6, 7). This indicates that recruitment of methylation-
dependent repressive factors rather than a direct effect of cyto-
sine methylation on the transcriptional machinery is responsible
for silencing.
Biochemical studies identified proteins that bind to methylated
DNA in vitro and had the properties expected of methylation-
dependent transcriptional repressors. However, ablation of the
genes that encode MeCP2 and other methylation-dependent
DNA-binding proteins singly or in combination did not reac-
tivate methylated promoters in vivo (8). Ablation of methylated
DNA-binding proteins produces phenotypes that are much less
severe than the phenotypes caused by deletions of DNA methyl-
transferase genes (9).
The components of the methylation-dependent repressive
complex and the actual mechanisms that repress transcription
are not known. The repression of methylated retrotransposon
promoters requires the TRIM28 protein (also known as KAP1
and TIF1β) (10), as does the methylation-dependent monoallelic
expression of imprinted genes (11), but TRIM28 is a structural
factor that does not bind to DNA and lacks repressor activity (12,
13). We developed a combined genetic and biochemical screen
to identify factors that interact with TRIM28 in a methylation-
dependent manner. The only such factor that was strongly
enriched in this screen was O-linked β-N-acetylglucosamine
transferase (OGT), the sole protein glycosyltransferase that is
active in the nucleus and cytoplasm. OGT has important regula-
tory functions in multiple pathways (14), but had not previously
been directly related to DNA methylation. Whole-genome anal-
ysis showed that TRIM28 and proteins modified by OGT coloc-
alize at transposon promoters and at imprinting control regions. In
the absence of DNA methylation, multiple proteins with key roles
in gene silencing failed to undergo modification by OGT. Tar-
geted protein deglycosylation by a novel editing method reac-
tivated the transcription of methylated retrotransposon promoters.
These data show that O-glycosylation is an essential component of
the system that represses methylated promoters.
Results
Ablation of TRIM28 Phenocopies Mutations that Cause Genome-Wide
Demethylation. Homozygosity for a strongly hypomorphic allele of
Trim28 in mouse embryos does not cause appreciable demethylation
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of DNA (SI Appendix, Fig. S1 A and B) but phenocopies the
reactivation of intracisternal A-type particles (IAP) retrotransposons
induced by genome-wide demethylation (4), as had been pre-
viously reported for a null allele of Trim28 (10). As in the case of
reactivated IAP retrotransposons, biallelic expression of imprinted
genes caused by the hypomorphic Trim28 mutation (11) did not
involve significant demethylation of imprinting control regions (SI
Appendix, Fig. S2). These data identify TRIM28 as an essential
mediator of methylation-dependent silencing of transposons and
methylation-dependent monoallelic expression of imprinted
genes. However, TRIM28 does not bind to DNA directly nor does
it possess intrinsic repressive activity and cannot be the ultimate
effector protein that represses methylated promoters (12, 13).
Demethylation did not cause dissociation of TRIM28 from IAP
retrotransposon sequences (SI Appendix, Fig. S3), which implicates
an unknown factor in the repression of methylated promoters.
Methylation-Dependent Association of OGT with the TRIM28
Complex. We developed a screen in which the composition of
TRIM28 complexes in demethylated Dnmt1−/− cells was compared
to that of Dnmt1+/+ cells that had normal genomic methylation
patterns. The only protein that showed a strong methylation-
dependent association with TRIM28 was OGT (Fig. 1 A and B
and SI Appendix, Table S1). OGT showed a methylation-
dependent association with TRIM28 that was >2-fold greater
than any other protein. This result was unexpected, as there had
been no prior connection between DNA methylation and protein
glycosylation (Fig. 1C and ref. 14).
TRIM28 and O-GlcNAcylated Proteins Cooccupy Methylated Regulatory
Sequences. Whole-genome chromatin immunoprecipitation fol-
lowed by DNA sequencing (ChIP-seq) using an antibody against
O-GlcNAc revealed that long terminal repeats (LTRs) of IAP
retrotransposons (the most actively proliferating retrotransposon
in the mouse genome (15)) are densely occupied by O-
GlcNAcylated proteins (Fig. 2A). Comparison of the ChIP-seq
profiles of O-GlcNAc and TRIM28 showed that LTRs are cooc-
cupied by TRIM28 and O-GlcNAcylated proteins (Fig. 2B). In
contrast, DNA transposons that are incapable of transcription are
not bound by O-GlcNAcylated proteins (Fig. 2B). While both
LTRs have similar or identical sequences, the 5′ LTRs that con-
tain the promoter are more densely O-GlcNAcylated (Fig. 2A).
All tested subfamilies of IAP retrotransposons were enriched in
both TRIM28 and O-GlcNAc (Fig. 2B).
Imprinting control regions (ICRs), which depend on DNA
methylation for allele-specific expression (5), were inspected for
occupancy by TRIM28 and O-GlcNAc. As shown in Fig. 2C,
major ICRs recruited peaks of both TRIM28 and O-GlcNAc. All
ICRs tested were enriched in either TRIM28 or O-GlcNAcylated
proteins; the large majority was enriched in both (Fig. 2D).
Genome Demethylation Causes Loss of O-GlcNAc from Proteins
Complexed with TRIM28. Proteins subject to methylation-dependent
O-GlcNAcylation were isolated from nuclear extracts of Dnmt1−/−
and Dnmt1+/+ ES cells by immunoprecipitation with antibodies to
TRIM28 followed by collection by the GlcNAc-specific lectin
Wheat Germ Agglutinin (WGA) and identification by mass
spectrometry. As shown in Fig. 3A, genome demethylation in
Dnmt1−/− ES cells caused a loss of O-GlcNAc from multiple
proteins complexed with TRIM28. The proteins showing the
greatest degree of methylation-dependent O-GlcNAcylation
are shown in Fig. 3B and SI Appendix, Table S2.
Multiple factors with known roles in transcriptional repression
were found to undergo methylation-dependent O-GlcNAcylation.
Many of these proteins had been previously reported to interact
with each other directly or indirectly (Fig. 3B). TRIM28 assembles
into a multiprotein complex containing HDAC1 and KDM1A
(16), and ZFP198 stabilizes the repressive KDM1A-CoREST-
HDAC1 complex on chromatin (17). The TRIM28-HDAC1-
KDM1A complex has been reported to interact with CHD4 and
SNF2H (18), and SF3B1 is a member of the SNF2H-WSTF si-
lencing complex and a key mediator of Polycomb-dependent
Hox gene repression (19), which is itself dependent on O-
GlcNAcylation (20).
Each of the proteins subject to DNA methylation-dependent
O-GlcNAcylation is involved in gene-silencing pathways. HDAC1
and KDM1A have been reported to repress retrotransposon tran-
scription (16, 21), and MOV10 restricts LINE-1 retrotransposition
Fig. 1. Identification of proteins in methylation-dependent TRIM28 com-
plexes. (A) Native TRIM28 complexes were immunopurified from nuclear
lysates of wild-type (Dnmt1+/+) and Dnmt1−/− ES cells. Mass spectrometry
analysis identified OGT as the protein most strongly dependent on DNA
methylation for interaction with TRIM28. All proteins represented by three
or more peptides are shown. A pseudocount of 1 was added to all peptide
counts to allow for representation on the log plot shown. (B) Confirmation
by immunoblot of the methylation-dependent association of OGT with
TRIM28 complexes. (C) Reversible O-GlcNAcylation of serine and threonine
by OGT and OGA at (Left) phosphorylation and (Right) dephosphorylation.
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Fig. 2. Methylated retrotransposon promoters and imprinting control regions are bound by TRIM28 and O-GlcNAcylated proteins. (A) Representative ChIP-
seq data showing colocalization of O-GlcNAc and TRIM28 at IAPEz retrotransposons. The 5′ LTRs that contain the U3 promoter region and the Gag region are
cooccupied by O-GlcNAcylated proteins and TRIM28. Type I is a 7-kb full-length element containing three ORFs (e.g., Gag, Prt, and Pol); type IΔ1 has a deletion
of Prt and part of Gag, resulting in a single ORF that encodes a novel GAG-POL fusion protein. IAPEz type IΔ1 is the most highly reactivated subtype after
removal of O-GlcNAc at LTRs (Fig. 4E). Similar strong reactivation of IAPEz IΔ1 is observed in both Dnmt1−/− and Trim28−/− cells (SI Appendix, Fig. S1B). (B)
TRIM28 and O-GlcNAc cooccupy all subtypes of LTRs. In contrast, DNA transposons, which are inactive in the mouse genome, are not occupied by TRIM28 or
O-GlcNAcylated proteins. ChIP-seq signal of O-GlcNAc corresponds to the ratio of the mean of ChIP triplicates to the mean of input duplicates. ChIP-seq signal
of TRIM28 is the ratio of the mean of ChIP duplicate to IgG control. Transposon subfamilies were categorized according to RepeatMasker annotation. (C)
Genome browser views of ChIP-seq data showing cooccupancy of TRIM28 and O-GlcNAc at the indicated ICRs. The Kcnq1ot1, Peg3, and Impact ICRs are
maternally methylated; Dlk1/Gtl2 ICR (also known as IG-DMR) is paternally methylated. (D) TRIM28 and O-GlcNAcylated proteins are bound to all ICRs. ChIP-
seq signals are the same as in B. ICR sequences were from ref. 46; TRIM28 ChIP-seq data were from ref. 45.
14294 | www.pnas.org/cgi/doi/10.1073/pnas.1912074117 Boulard et al.
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(22). SNF2H and HDAC1 are required for the maintenance of
silent chromatin (23). The CHD4-HDAC1 complex (also known as
the NuRD complex) has nucleosome remodeling and histone
deacetylase activity (24), and O-GlcNAcylation of HDAC1 stimu-
lates its histone deacetylase activity and augments transcriptional
silencing (25). Recessive mutations in the CUL7 gene, whose
product is complexed with FBXW8, causes greatly reduced ex-
pression of the imprinted IGF2 gene and increased expression of
H19 in human 3M syndrome type 1 without loss of allele-specific
DNA methylation, which indicates that CUL7 is involved in the
methylation-dependent imprinted expression of H19 and IGF2
(26, 27).
We confirmed that HDAC1, SNF2H, CHD4, ZFP198, and
SF3B1 bear O-GlcNAc in ES cells and also found that 12 other
proteins involved in transcriptional regulation were subject to
O-GlcNAcylation (SI Appendix, Fig. S4). All DNA methyl-
transferases and all tested histones and histone variants were
also O-GlcNAcylated. TRIM28 itself was the only silencing
factor found to lack detectable O-GlcNAc. The number of fac-
tors subject to O-GlcNAcylation was larger than expected;
GlcNAcylation has important roles in the regulation of transcription
(28) but has received much less attention than posttranslational
modifications such as acetylation, methylation, phosphorylation, or
ubiquitylation.
Targeted deGlcNAcylation Reactivates Methylated Transposable
Elements. To test whether O-GlcNAcylation is required for
methylation-dependent transcriptional repression, a new exper-
imental approach was required, as genetic ablation of Ogt causes
cell lethality (29). We therefore developed a new method to
selectively deGlcNAcylate proteins bound to IAP retrotransposon
promoters, which are Pol II-dependent promoters that are repressed
by DNA methylation (4) but are not required for cell viability. We
targeted the very well-characterized prokaryotic O-GlcNAc hy-
drolase (OGA BtGH84) from Bacteroides thetaiotamicron (30) to
LTRs of endogenous IAP retrotransposons. A Cas9 expression
vector was produced in which both Cas9 endonuclease domains
had been inactivated by point mutations to produce a catalytically
dead Cas9 (dCas9) that retained single guide RNA (sgRNA)-de-
pendent DNA binding. An embryonic stem (ES) cell line was
engineered to conditionally express a chimeric protein consisting
of B. thetaiotamicron OGA fused to dCas9, together with four
sgRNAs directed against the U3 promoter region of IAP retro-
transposons (Fig. 4 A and B). The same fusion protein that con-
tained a D242A mutant form of OGA that is unable to bind or
hydrolyzeO-GlcNAc (30) served as a control. As shown in Fig. 4C,
both the dCas9-OGA and dCas9-OGAD242A fusion proteins were
stable and expressed at very similar levels.
The dCas9-OGA or dCas9-OGAD242A fusion protein did not
demethylate IAP proviral DNA (Fig. 4D), but the dCas9-OGA
fusion protein induced a dramatic reactivation of IAP tran-
scription (Fig. 4E). This strong release from silencing was spe-
cific to the subclass of IAP elements targeted (IAPEz) as other
types of LTR transposons and non-LTR transposons remained
repressed (SI Appendix, Fig. S5). The inactive dCas9-OGAD242A
fusion protein had no detectable effect, which indicates that
reactivation was the result of deGlcNAcylation and not an effect
of the binding of the dCas9-OGA-sgRNA complex. The RNA
blot data were confirmed and quantitated by the RNA-seq data
shown in Fig. 4F. The level of derepression was greater than that
caused by demethylation, which may reflect the existence of both
methylation-dependent (4) and methylation-independent mech-
anisms (31) of IAP repression. The data indicate that O-
GlcNAcylation is required for both mechanisms of repression.
However, the fact that methylated IAP retrotransposon pro-
moters was reanimated by targeting the dCas9-OGA fusion
protein to IAP promoters provides strong evidence that O-
glycosylation mediates transcriptional repression.
Other direct evidence for a role of protein O-glycosylation in
the silencing of retrotransposon comes from studies of a liver-
specific deletion of Ogt in mice (32). We reanalyzed the RNA-
seq data from this study for transposon reactivation. As shown in
Fig. 4G, robust reanimation of multiple LTR transposons was
apparent in deGlcNAcylated Ogt−/− liver tissue prior to necrotic
cell death. This result shows that genome-wide deGlcNAcylation
reactivates multiple classes of methylated retrotransposons,
whereas targeted deGlcNAcylation reactivates only the selected
retrotransposon family.
Discussion
While many glycosyltransferases modify secreted proteins and
the extracellular domains of membrane proteins, OGT is the only
glycosyltransferase that modifies nuclear and cytosolic proteins,
and O-GlcNAcylation is the only form of glycosylation that is
known to be highly dynamic and reversible (14). O-GlcNAcylation
antagonizes phosphorylation of Ser and Thr, and while phos-
phorylation adds a strong anion that rearranges salt bridges (33),
O-GlcNAcylation of the same residues introduces a cluster of
hydrogen bond donors and acceptors that induce very different
structural transitions in target proteins (Fig. 1C). Many repres-
sive factors associated with TRIM28 complexes are subject to
methylation-directed O-GlcNAcylation, which indicates that re-
pression of methylated promoters is likely to be the result of O-
GlcNAcylation of multiple chromatin factors.
There is abundant evidence for an important regulatory role of
O-GlcNAcylation in gene expression, but no prior association
with DNA methylation. O-GlcNAcylation is involved in many
regulatory pathways; these include control of the interaction of
YY1 with Rb1, which prevents YY1 from activating transcription
(34), and STAT5 (35) and the pluripotency factor OCT4 (36)
that are only active when O-GlcNAcylated. It is also of great
Fig. 3. Methylation-dependent O-GlcNAcylation of protein associated with
TRIM28. (A) Methylation-dependent O-GlcNAcylation of TRIM28-associated
proteins. Nuclear extracts from wild-type (WT) and Dnmt1−/− ES cells were
subjected to native immunoprecipitation with anti-TRIM28 antibodies and
analyzed by immunoblotting with anti-GlcNAc antibodies. Arrows at right
indicate multiple proteins that are O-GlcNAcylated only in cells with meth-
ylated genomes. (B) Identification of TRIM28 interactors with methylation-
dependent O-GlcNAcylation. Sequential immunoprecipitation with anti-
TRIM28 and collection of O-GlcNAcylated proteins on WGA beads fol-
lowed by analysis by mass spectrometry was used to identify proteins asso-
ciated with TRIM28 in a DNA methylation-dependent manner. Each of the
proteins shown was represented by >6 unique peptides and was depleted by
>2-fold in Dnmt1−/− cells. Connecting lines indicate reported interactions
among the proteins identified. Proteins that have previously been impli-
cated in the repression or restriction of retrotransposons or retroviruses (see
text) are marked with asterisks. x axis is dimensionless.
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interest that O-GlcNAcylation of the C-terminal domain (CTD)
of the large subunit of RNA Pol II inhibits phosphorylation of
the CTD and transcriptional elongation (37, 38). It is particularly
intriguing that all Polycomb-mediated gene repression in Dro-
sophila is dependent on the single Ogt gene (super sex combs or
sxc) in the fly genome, even though Polycomb factors are bound
to their normal sites in the sxc mutant (20).
The targeting of the repressive complex that contains TRIM28
and OGT to methylated promoters and imprinting control re-
gions is likely to involve the very large and rapidly evolving group
of KRAB-Zinc finger proteins that are restricted to tetrapod
vertebrates and are especially numerous and diverse in mammals
(39). We propose a model under which a class of methylation-
independent KRAB-Zinc finger proteins nucleate TRIM28
complexes that lack OGT while methylation-dependent KRAB-
Zinc finger proteins recruit TRIM28 and activate OGT. Cheng
and colleagues estimate that ∼200 of >300 human KRAB-Zinc
finger proteins are likely to display methylation-dependent
binding to DNA (40). As shown in SI Appendix, Fig. S6 and SI
Appendix, Table S3, many Zinc finger proteins are complexed
with TRIM28. The most highly enriched KRAB-Zinc finger
protein in TRIM28 complexes is Zfp568, which is required solely
for the methylation-dependent imprinted expression of the Igf2
gene (41). The data presented here support a model under which
methylated regulatory sequences are bound in a sequence- and
methylation-dependent manner by one or more of the many
KRAB-Zinc finger proteins; this nucleates a methylation-specific
complex of proteins that includes TRIM28 and OGT (SI Ap-
pendix, Fig. S7). We propose that subsequent O-GlcNAcylation
induces structural transitions in multiple chromatin factors that
modify or enhance their repressive activities to impose tran-
scriptional repression on methylated promoters and to mediate
monoallelic expression of imprinted genes.
Materials and Methods
ES Cells. The ES cell line homozygous for a null allele ofDnmt1 (Dnmt1−/−) was
described previously (42). ES cells were cultured on gelatin-coated plates
under standard conditions (DMEM, 2 mM Glutamax, 15% ES grade FBS,
2 mM L glutamine, MEM nonessential amino acids, 100 IU/mL penicillin,
Fig. 4. Reactivation of methylated promoters after targeted deGlcNAcylation. (A) An ES cell line was modified to express a dCas9-OGA fusion protein and
four sgRNAs complementary to the U3 promoter region of IAP retrotransposons of the abundant IAPEz family. dCas9 from Streptococcus pyogenes had the
RuvC endonuclease domain inactivated by a D10A substitution, and the HNH domain was inactivated by H839A and N863 substitutions. The coding region of
the Bacteroides OGA gene (BtGH84) was synthesized and optimized for mammalian codon usage. The dCas9-OGA fusion protein was flanked by SV40 nuclear
localization signals and by FLAG epitopes. The inducible cassette exchange system Plox-AinV15 was used to integrate the cDNA coding dCas9-OGA down-
stream of a Tet-On inducible promoter (pTRE). Tet-On regulation was provided via rtTA in trans. (B) sgRNA targets mapped to the IAP U3 promoter region.
Dark vertical bars indicate position of CpG dinucleotides. (C) Immunoblot analysis of doxycycline-induced dCas9-OGA and dCas9-OGAD242A proteins shows
equal expression of each stable fusion protein. (D) Expression of the dCas9-OGA and dCas9-OGAD242A proteins as in C did not cause detectable demethylation
of IAP proviral DNA, as determined by DNA blot hybridization after cleavage with the methylation-sensitive restriction endonuclease HpaII. (E) RNA blot
hybridization shows that targeting of dCas9-OGA protein to IAP U3 regions induces strong reactivation of IAP transcription; the inactive dCas9-OGAD242A
mutant had no effect. (F) RNA-seq analysis confirms reactivation of IAP transcription by demethylation and by dCas9-OGA. RNA-seq read counts
were >29,700,000 per sample. Axes are labeled in counts per million. (G) Reanalysis of RNA-seq data after liver-specific deletion of Ogt (32) shows strong
reactivation of major ERVK transposons prior to death of the mutant cells by necrosis.
14296 | www.pnas.org/cgi/doi/10.1073/pnas.1912074117 Boulard et al.
D
ow
nl
oa
de
d 
at
 S
E
R
IA
LS
 D
E
P
A
R
T
M
E
N
T
, W
A
S
H
IN
G
T
O
N
 U
N
IV
E
R
S
IT
Y
 o
n 
A
ug
us
t 9
, 2
02
0 
100 μg/mL streptomycin, 0.12 mM 2-mercaptoethanol and leukemia
inhibitory factor).
Nuclear Extract Preparation. ES cells were harvested at 80% confluency and
resuspended in hypotonic lysis buffer (10 mM Hepes pH 7.65, 10 mM KCl,
1 mM MgCl2, 0.5 mM DTT, and complete protease inhibitors [Roche]) and
incubated for 15 min on ice. Cells were treated with a Dounce homogenizer
(25 strokes with tight pestle). Nuclei were recovered by centrifugation (10min
at 300 g at 4 °C), washed twice in buffer A (10 mM Hepes pH 7.65, 1 mM
MgCl2, 0.5 mM DTT, 250 mM Sucrose, and complete protease inhibitors
[Roche]), centrifuged (2,800 g for 10 min at 4 °C), and resuspended in buffer
B (20 mM Hepes pH 7.65, 25% glycerol, 250 mM NaCl, 5 mM MgCl2, 0.2mM
EDTA, 0.005% Nonidet P-40, 0.5 mM DTT, and complete protease inhibitors
[Roche]). NaCl concentration was increased to 300 mM, and extraction of the
soluble protein complexes was allowed to proceed under gentle agitation
for 3 h at 4 °C. Nuclei were pelleted by centrifugation (3,000 g for 10 min at
4 °C), and the supernatant was collected as the nuclear soluble extract.
Protein concentration was measured by bicinchoninic acid assay.
Proteomic Screen for Methylation-Dependent TRIM28 Associated Proteins. Ten
micrograms of anti-TRIM28 monoclonal antibody (MAB3662, EMD Millipore)
bound to 50 μL Dynabeads Protein G magnetic beads (Thermo Fisher Sci-
entific) was incubated with 8 mg of ES cell nuclear soluble extract for
14–16 h at 4 °C. Bound material was eluted by incubating the beads at 95 °C
for 5 min in a buffer containing 10 mM Hepes pH 7.65, 0.1% sodium dodecyl
sulfate (SDS), 1% Nonidet P-40, 1 mM DTT, 300 mM NaCl. Complexes were
resolved by SDS/PAGE, stained by SYPRO Ruby (Thermo Fisher Scientific), and
identified by mass spectrometry at the Taplin Biological Mass Spectrometry
Facility (Harvard Medical School, Boston, MA).
ChIP-seq. Chromatin immunoprecipitation was carried out on formaldehyde
cross-linked chromatin. One hundred million ES cells were fixed for 10 min at
room temperature with 1.1% formaldehyde and quenched with 125 mM gly-
cine. Soluble chromatin was sheared by sonication to an average size of 250 bp
using a Covaris S220 Sonicator with peak power 150, duty factor 25, cycles/burst
200. Immunoprecipitation was carried out overnight at 4 °C with 3 μg of
monoclonal antibodies anti-O-GlcNAc (Thermo Fisher Scientific, MA1-076)
bound to 10 μL Dynabeads conjugated with protein G (Life Technologies). Beads
were washed and chromatin eluted as described previously (43). Immunopre-
cipitated DNA and input DNA were submitted to library preparation using the
NEBNext Ultra II DNA Library Prep Kit for Illumina (New England Biolabs) fol-
lowing the manufacturer’s instructions and amplified for 15 cycles. The samples
were sequenced in single-end mode on the Illumina NextSEq 500 platform at
the European Molecular Biology Laboratory’s (EMBL) Genomics Core Facility.
ChIP-seq Data Analysis. ChIP-seq reads were mapped to the mouse genome
(mm10) using bowtie2 (v2.2.2) and default parameters. Duplicate reads were
removed using samtools rmdups (v1.3.1). The Macs2 (v2.0.10) callpeaks
module was used to call peaks using -g 1.87e9, –SPMR, and -B flags and using
the input as background (44). TRIM28 ChIP-seq reads were downloaded
from GEO GSE59189 (45) and processed similarly. The coordinates of ICRs are
described in ref. 46.
Lectin-Based Purification of O-GlcNAcylated Proteins. O-GlcNAcylated proteins
were isolated with WGA conjugated to magnetic beads (47). O-GlcNAcylated
proteins were isolated either from fractionated nuclei or from isolated
TRIM28 complexes. The O-GlcNAase inhibitor PUGNAc (Tocris Biosciences)
was added at 2 mM in hypotonic lysis buffer, buffer A and B in order to
preserve physiological O-GlcNAc levels during the cellular fractionation
procedure. Nuclei were lysed with 1% SDS, cleared of nucleic acids by
treatment with Universal Nuclease (Pierce), and denatured by heating to
100 °C for 2 min in 1% SDS. Denatured proteins were incubated for 2 h at
4 °C with 200 μL of Dynabeads Streptavidin C1 (Thermo Fisher Scientific)
bound to 200 μg of biotin-conjugate wheat germ agglutinin (Sigma). Beads
were washed six times with 20 mM Hepes pH 7.65, 250 mM NaCl, 5 mM
CaCl2, 1 mM MgCl2, 0.2% Nonidet P-40. GlcNAcylated proteins were eluted
from the beads at 95 °C. The specificity of binding was controlled by com-
petitive inhibition with 0.75 M N-acetylglucosamine.
Coexpression of dCas9-OGA and sgRNA Targeted to IAP U3 Regions in ES Cells.
The chimeric protein dCas9-OGA was coexpressed with four sgRNA specific
to the U3 region of the IAP retrotransposon in the tetracycline-inducible
(Tet-On) gene expression system PLox-AinV15, which is designed to insert
a circular Plox plasmid by cre/lox recombination into a recombinant doxycycline-
inducible locus. The AinV15 cell line carries the reverse tetracycline trans-
activator (rtTA) integrated into the ubiquitously expressed ROSA26 locus (48).
The complementary DNA (cDNA) encoding the dCas9-OGA fusion protein as
well as four human U6 promoters driving expression of the sgRNAs were cloned
into the P2lox vector (Adgene #34635). The mammalian codon-optimized en-
zymatically inactive Cas9 from Streptococcus pyogenes (dCas9 which bears the
substitutions D10A, H839A, H840A, and N863A) fused to an N-terminal SV40
nuclear localization signal sequence, and a FLAG tag epitope was amplified by
polymerase chain reaction (PCR). The mammalian codon-optimized OGA (30)
from Bacteroides thetaiotaomicron GH84 (UniProtKB - Q89ZI2) fused to a
C-terminal SV40 nuclear localization sequence and a FLAG tag epitope was
synthesized using IDT gBlocks gene fragments (Integrated DNA Technologies).
The DNA fragments encoding dCas9 and OGA were ligated into the SalI and
the NotI sites of the P2lox vector using Gibson cloning (NEBuilder HiFi DNA
Assembly Cloning Kit, NEB). The sgRNAs homologous to the IAP LTRs (Fig. 4B)
were cloned between the BbsI sites of the px330 plasmid (Adgene #42230) to
permit PCR amplification of the DNA sequences that contain the U6 promoter,
the sgRNA, and the tracrRNA. The four DNA fragments containing U6 promoter
and sgRNAwere assembled together and cloned into the BsrGI site of the P2Lox
plasmid via Gibson assembly (NEBuilder HiFi DNA Assembly Cloning Kit, NEB).
The sequences of the sgRNAs are provided in SI Appendix, Table S4. The D242A
mutation was previously shown to abolish OGA enzymatic activity and its
binding to GlcNAc (30) and was generated by site-directed mutagenesis
(Agilent Technologies).
Three million AinV15 ES cells were nucleofected with 10 μg of P2Lox
plasmid containing the dCas9-OGA cDNA and four U6 promoter-driven
sgRNAs and 10 μg of a plasmid-expressing Cre recombisase (Adgene
#11543). Recombinant cells were selected by treatment with 350 μg/mL G418
and genotyped for proper integration by PCR as previously described (48).
Expression of the dCas9-OGA transgene was induced by addition of 1 μg/mL
of doxycycline (Sigma). After 48 h of induction, cells were harvested, and
RNA, proteins, and genomic DNA were extracted for analyses.
RNA Blot Hybridization. Total RNA was isolated using TRIzol reagent (Thermo
Fisher Scientific) from a pool of six embryos of same genotype dissected at
embryonic day E8.5 or from 1 × 106 ES cells. RNA was cleared of potential con-
taminating genomic DNA by two rounds of digestion with DNase (Turbo DNase,
Ambion) and quantified using Qubit Fluorometric Quantitation (Thermo Fisher
Scientific). Ten micrograms of total RNA was denatured and subjected to elec-
trophoresis in a 1% agarose gel containing 1.9% formaldehyde prior to transfer
to a nitrocellulose membrane. After ultraviolet cross-linking, the membrane was
hybridized with a radiolabeled IAP probe as described (49). TheGapdh probe was
cloned from cDNA using the primers described in SI Appendix, Table S4.
RNA-seq. Total RNAwas extracted, and traces of contaminating genomic DNA
were eliminated by two successive treatments with DNase (Turbo DNase,
Ambion). The integrity of the RNA was verified using the Bioanalyzer RNA
2100 Nano Assay (Agilent Technologies). RNA-seq libraries were prepared
with the TruSeq Stranded mRNA LT (Illumina), and massive parallel se-
quencing was performed in single-end reads using an Illumina HiSeq 4000
and Next-seq instruments. We obtained 38,676,845, 40,766,737, and
36,497,140 reads for three replicates of Dnmt1−/− ES cells; and 40,282,098,
50,062,039, and 36,948,128 reads for three replicates of wild-type ES cells.
Further, 38,798,921 and 38,840,713 reads were obtained for dCas9-OGAWT-
expressing cells and dCa9-OGAD242A-expressing ES cells, respectively.
For IAPEz expression analysis, reads were mapped to the mouse reference
genome (mm10) using bowtie2 (v2.2.2; ref. 50) and default parameters ex-
cept for -D 10000 -R 10000. After filtering out reads that mapped to ribosomal
RNA (rRNA) and messenger RNA (Ensembl v87) sequences, reads were over-
lapped with repeat annotations from the RepeatMasker track from the Uni-
versity of California Santa Cruz genome browser using featureCounts (v1.5.0)
(50). Reads for individual repeat element families (e.g., IAPEz) were normal-
ized to FPKM (fragments per 1000 bp per million reads). FPKM values from
IAPEz were then background-adjusted using the FPKM value from all DNA
transposons and then rescaled back to cpm (counts per million). For transcript
analysis, reads were mapped to the mouse reference genome (mm10) using
HISAT2 (v2.1.0) provided with known splice sites using Ensembl v87 and oth-
erwise default parameters (51). After removal of rRNA sequences, alignment
files were overlapped with gene annotations using featureCounts (v1.5.0; ref.
52) and Ensembl v87. Expression counts were normalized to cpm, and log2 fold
change values were calculated using DESeq2.
Data Availability. The RNA-seq and ChIP-seq data reported in this study are
available in the Gene Expression Omnibus (GEO) database (accession no.
GSE93539).
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